These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27555565)

  • 1. Excellent remission rates with limited toxicity in relapsed/refractory Langerhans cell histiocytosis with pulse dexamethasone and lenalidomide in children.
    Uppuluri R; Ramachandrakurup S; Subburaj D; Bakane A; Raj R
    Pediatr Blood Cancer; 2017 Jan; 64(1):110-112. PubMed ID: 27555565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Treatment of Refractory Langerhans Cell Histiocytosis of the Choroid Plexus in a Child With Pulse Dexamethasone and Lenalidomide.
    Uppuluri R; Ramachandrakurup S; Balaji R; Subburaj D; Bakane A; Raj R
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e74-e78. PubMed ID: 28099396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
    Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
    Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review].
    Yao X; Ying H; Weihong Z; Qing S; Xintian L
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X).
    Viana MB; Oliveira BM; Silva CM; Rios Leite VH
    Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.
    Rodriguez-Galindo C; Kelly P; Jeng M; Presbury GG; Rieman M; Wang W
    Am J Hematol; 2002 Mar; 69(3):179-84. PubMed ID: 11891804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
    Hopfinger G; Nösslinger T; Lang A; Linkesch W; Melchardt T; Weiss L; Egle A; Greil R
    Ann Hematol; 2014 Mar; 93(3):459-62. PubMed ID: 24441915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].
    Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J
    Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the relapsed/refractory myeloma patient: strategies incorporating lenalidomide.
    Richardson P
    Semin Hematol; 2005 Oct; 42(4 Suppl 4):S9-15. PubMed ID: 16344100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis.
    Abraham A; Alsultan A; Jeng M; Rodriguez-Galindo C; Campbell PK
    Pediatr Blood Cancer; 2013 Jun; 60(6):E19-22. PubMed ID: 23255383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of multiple relapsed-refractory Langerhans cell histiocytosis with cyclosporine.
    Özyörük D; Yozgat AK; Kaçar D; Yazal Erdem A; Işık M; Güzelküçük Z; Hacısalihoğlu Ş
    Tumori; 2021 Dec; 107(6):NP120-NP122. PubMed ID: 34423687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
    Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
    Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis].
    Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
    Apollonsky N; Lipton JM
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent and Refractory Langerhans Cell Histiocytosis in Children Treated with the Combination of Cladribine and Cytarabine].
    DU Y; Xiong H; Li H; Li JX; Tao F; Yang L; Lu WJ; Qi SS; Zhang LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):943-949. PubMed ID: 35680831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lenalidomide proved effective in multisystem Langerhans cell histiocytosis.
    Szturz P; Adam Z; Rehák Z; Koukalová R; Slaisová R; Stehlíková O; Chovancová J; Klabusay M; Krejčí M; Pour L; Hájek R; Mayer J
    Acta Oncol; 2012 Mar; 51(3):412-5. PubMed ID: 22103591
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients].
    Grau J; Ribera JM; Tormo M; Indiano JM; Vercher J; Sandoval V; Ramírez G; Sastre A; Flores E; García-Conde J
    Med Clin (Barc); 2001 Mar; 116(9):339-42. PubMed ID: 11333766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine.
    Mottl H; Starý J; Chánová M; Nekolná M; Drahokoupilová E; Smelhaus V
    Leuk Lymphoma; 2006 Sep; 47(9):1881-4. PubMed ID: 17065001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofarabine in refractory Langerhans cell histiocytosis.
    Rodriguez-Galindo C; Jeng M; Khuu P; McCarville MB; Jeha S
    Pediatr Blood Cancer; 2008 Nov; 51(5):703-6. PubMed ID: 18623218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.